Journal
IMMUNOLOGY LETTERS
Volume 199, Issue -, Pages 36-43Publisher
ELSEVIER
DOI: 10.1016/j.imlet.2018.05.002
Keywords
Tumor exosome; Dendritic cell; Immune response; T cell differentiation
Categories
Funding
- National Natural Science Foundation of China [81672799, 31500731]
- Changzhou Sci Tech Program [CJ20159056]
- Changzhou High-Level Health Personnel Training Project [2016CZLJ016, 2016CZBJ013]
Ask authors/readers for more resources
Tumors can induce the generation and accumulation of immunosuppression in a tumor microenvironment, contributing to the tumor's escape from immunological surveillance. Although tumor antigen-pulsed dendritic cell can improve anti-tumor immune responses, tumor associated regulatory dendritic cells are involved in the induction of immune tolerance. The current study sought to investigate whether exosomes produced by tumor cells had any effect on DCs in immune suppression. In this study, we examined the effect of tumor exosomes on DCs and found that exosomes from LLC Lewis lung carcinoma or 4T1 breast cancer cell blocked the differentiation of myeloid precursor cells into CD11c(+) DCs and induced cell apoptosis. Tumor exosome treatment inhibited the maturation and migration of DCs and promoted the immune suppression of DCs. The treatment of tumor exosomes drastically decreased CD4(+)IFN-gamma(+) Th1 differentiation but increased the rates of regulatory T (Treg) cells. The immunosuppressive ability of tumor exosome-treated DCs were partially restored with PD-L1 blockage. These data suggested that PD-Ll played a role in tumor exosome-induced DC-associated immune suppression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available